Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Influence of Perfluorocarbon Liquid (LIQUID) During Pars Plana Vitrectomy on Retinal Vessel Displacement in Primary Macula-involving Rhegmatogenous Retinal Detachment

Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust

NCT ID: NCT07027098

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Perflurocarbon liquid (procedure), Without Perflurocarbon liquid (procedure)
How long the study runs
Study runs about 24 months (dates as stated)
About the drug or intervention
Perflurocarbon liquid — procedure: Used to facilitate surgery of retinal detachment to stabilise macular during surgery. · Without Perflurocarbon liquid — procedure: Standard retinal detachment surgery (vitrectomy) without the use of Perflurocarbon liquid (PFCL).
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years and over
Who
All
Number of participants
292
Started
2025-10-28
Last checked
2026-04

Plain English Summary

What is this study?

  • • Testing a new treatment for retinal displacement after retinal detachment surgery
  • • NA - 292 participants
  • • Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, with an incidence of approximately 10 per 100,000 people

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with retinal displacement after retinal detachment surgery

Where?

  • • Norwich - Norwich University Hospitals NHS Foundation Trust

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, with an incidence of approximately 10 per 100,000 people. Surgical interventions for treating RRD include pars plana vitrectomy (PPV), which currently represents the main adopted surgical choice. Main outcomes of successful RRD surgery have mainly been represented by anatomical retinal reattachment and best-corrected visual acuity (BCVA). Despite successful surgery, patients with mac-off RRD often report postoperative visual complaints of distortion such as metamorphopsia and scotomas in their central visual field, with great variability. Major advances in retinal imaging including wide-field optical coherence tomography (OCT) and fundus autofluorescence (FAF) allowed to investigate morphological changes after RRD surgery. The concept of retinal displacement - where the retina has reattached but the exact location has shifted, as evidenced by retinal vessel printing shown on post operative retinal imaging. Postoperative retinal displacement has been observed to occur with different frequency in relationship to variables including postoperative tamponade, surgical technique, and intraoperative use of perfluorocarbon liquids (PFCL). The investigators hope to formally study the impact of intraoperative use of PFCL, which is used as an aid during surgery to help flatten and position the retina, on retinal displacement. This will help us better understand the impact of this tool on outcomes both objectively through retinal imaging, and subjectively through visual outcomes including visual acuity and measures of distortion and other visual disturbances.

More detail

Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, resulting from the separation of the neurosensory retina from the underlying retinal pigment epithelium (RPE). It is caused by at least one retinal break and recruitment of intraocular fluid into the subretinal space. Surgical interventions for treating RRD include pars plana vitrectomy (PPV), which currently represents the most widely adopted surgical choice, scleral buckling (SB) and pneumatic retinopexy (PnR). Significant visual loss is the main complaint of patients with macula-involving RRD (MIRD). Hence, the main outcomes of successful RRD surgery have historically been represented by postoperative anatomical retinal reattachment and best-corrected visual acuity (BCVA). However, despite successful surgery, patients with MIRD often report postoperative visual complaints of distortion such as metamorphopsia, aniseikonia and scotomas in their central visual field, with great variability. Major advances in retinal imaging contributed to provide a better understanding of postoperative visual complaints after surgery for RRD. In particular, optical coherence tomography (OCT) highlighted drop-out of the ellipsoid zone (EZ) or outer and inner retinal folds in the macula area. However, only more recently, hyperautofluorescent lines, also called Retinal Vessel Printing (RVP), adjacent to the retinal blood vessels, were noted on autofluorescence imaging in patients who underwent RRD surgery. This finding is believed to be secondary to unintentional retinal displacement after RRD surgery and may serve as a surrogate anatomical marker of postoperative metamorphopsia and central scotomas. Postoperative retinal displacement is potentially influenced by several variables including intraocular tamponade, adopted surgical technique, intraoperative use of perfluorocarbon liquids (PFCL) and postoperative posture. The effect of PFCL on retinal displacement is currently unknown due to lack of RCTs and significant limitations of previous research. Therefore, the aim of this RCT is to investigate the role of intraoperative PFCL on postoperative retinal displacement in patients with MIRD undergoing PPV with immediate postoperative face-down posture. The investigators aim to evaluate whether intraoperative PFCL affects the incidence and patterns of postoperative retinal displacement. As secondary outcomes, this RCT will also investigate the effect of intraoperative use of PFCL on functional outcomes, e.g. BCVA, metamorphopsia and aniseikonia. All patients participating in the trial will be randomly allocated to having surgery either with or without the use of PFCL, and will be followed up regularly after surgery for up to 6 months.

Retinal Displacement After Retinal Detachment Surgery

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓18 years of age, or older.
  • ✓Diagnosis of primary MIRD with posterior vitreous detachment, and fovea off (confirmed with OCT)
  • ✓Surgeons' decision that the patient is eligible for using gas as postoperative tamponade.
  • ✓The surgeon is confident to proceed with surgery with or without the use of intraoperative PFCL

Who cannot take part

  • ✗Previous RRD and/or RRD surgery in the study eye
  • ✗Decision to use adjunct scleral buckle
  • ✗Decision to use silicone oil as tamponade
  • ✗Retinal detachment with macula on
  • ✗Previous vitreoretinal surgery in the study eye
See the full criteria
Inclusion Criteria: * 18 years of age, or older. * Diagnosis of primary MIRD with posterior vitreous detachment, and fovea off (confirmed with OCT) * Surgeons' decision that the patient is eligible for using gas as postoperative tamponade. * The surgeon is confident to proceed with surgery with or without the use of intraoperative PFCL Exclusion Criteria: * Previous RRD and/or RRD surgery in the study eye * Decision to use adjunct scleral buckle * Decision to use silicone oil as tamponade * Retinal detachment with macula on * Patients with other retinal pathologies causing permanent structural changes to the retina in the study eye, such as diabetic retinopathy (assessed above background, or any diabetic maculopathy), previous vascular occlusion (artery or vein occlusion), macula dystrophy, among others * Previous vitreoretinal surgery in the study eye * Inability to come for follow ups up to 3 months * Inability to take FAF and OCT imaging due to neck stiffness or other medical issue * Mental incapacity * Patient is unwilling or unable to follow or comply with all study related procedures or to sign informed consent form. * Contraindications for PFCL * Previous enrollment in a clinical trial involving retinal diseases and/or treatments * Media opacity leading to poor quality retinal images (not including post operative significant cataract. See section 7.11) * Patient inability to posture following surgery

Where Is This Study? (1 UK site)

Norwich University Hospitals NHS Foundation Trust

Norwich NR4 7UY, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Francesco Sabatino

Sponsor contact

CONTACT

+441603 286286 francesco.sabatino@nnuh.nhs.uk

Sean Zhou

Sponsor contact

CONTACT

+441603 286286 Sean.Zhou@nnuh.nhs.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-04